Table 1 Participants’ characteristics at TB diagnosis or TB treatment completion
Characteristics | Number (%) N = 1,111 |
|---|---|
Characteristics at TB treatment completion | |
Sex | |
Female | 548 (49.3%) |
Male | 563 (50.7%) |
Age in years, median (IQR) | 36 (IQR 31, 42) |
16_24 | 74 (6.7%) |
25_34 | 396 (35.6%) |
35_44 | 449 (40.4%) |
45+ | 192 (17.3%) |
CD4 count (cells/mL) median (IQR ) | 235 (IQR:139, 366) |
<200 | 393 (42.4%) |
>=≥200 | 533 (57.6%) |
Body mass index (Kg/M2), median (IQR) | 22.0 (IQR 20.1, 24.2) |
< 18 | 86 (8.2%) |
≥ 18 | 964 (91.8%) |
HIV WHO clinical stage | |
Stage III | 463 (41.9%) |
Stage IV | 642 (58.1%) |
ART type | |
1st line | 1024 (92.2%) |
Other | 87 (7.8%) |
ART duration in years, median (IQR) | 1.0 (IQR: 1.0, 1.0) |
0 to 1 | 856 (77.1%) |
2 to 4 | 137 (12.3%) |
≥ 5 | 118 (10.6%) |
Characteristics at TB diagnosis | |
Calendar year of TB diagnosis | |
2008_2010 | 376 (33.8%) |
2011_2012 | 430 (38.7%) |
2013_2014 | 305 (27.5%) |
Hepatitis B status prior/during TB treatment | |
Negative | 728 (94.3%) |
Positive | 44 (5.7%) |
Anatomic site of TB | |
Pulmonary TB | 649 (59.2%) |
Extra pulmonary TB | 448 (40.8%) |
Type of TB diagnosis | |
Microbiological | 400 (36.0%) |
Clinical | 711 (64.0%) |
TB history | |
First episode | 956 (86.0%) |
Retreatment | 155 (14.0%) |